Oncology News

The occurrence of colorectal cancer in colonoscopies performed on patients aged between 45 and 50 years showed rates that approach those in ages 50 to 54 years, according to a presentation at Digestive Diseases Week.

Higher red blood cell transfusion rates correlated with higher odds for morbidity and mortality among patients who underwent elective GI cancer resection, according to a presentation at Digestive Disease Week.

Multi-target stool DNA screening tests predicted neoplasia at follow-up colonoscopy more often than fecal immunochemical test or colonoscopy alone, according to a presentation at Digestive Disease Week.

Endoscopy in patients aged younger than 50 years decreased the incidence of colorectal cancer, according to study estimates reported at Digestive Disease Week.

Primary care practitioners need increased education and recommendations for early-onset colorectal cancer screening practices, according to a presentation at Digestive Disease Week.

Researchers found higher rates of colorectal neoplasia correlated with male sex and increased age, according to a presentation at Digestive Disease Week.

In a video exclusive, Paul Limburg, MD, Mayo Clinic, told Healio adherence rates for stool-based colorectal cancer screening and colonoscopy informed comparative effectiveness and the need for improved screening and follow-up adherence.

In this video exclusive, Roi Anteby, MD, postdoctoral research fellow, department of surgery, Massachusetts General Hospital, discussed the affect of race, socioeconomic status and education on completion of adjuvant therapy for pancreatic cancer.

The COVID-19 pandemic disrupted colorectal cancer screening programs around the world.

Screening endoscopy among otherwise healthy individuals aged older than 75 years appeared to lower the risk for colorectal cancer incidence and cancer-associated mortality, according to study results published in JAMA Oncology.